ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Could a once-abandoned obesity drug be revived in osteoporosis?
December 26, 2018Irisin, the once much-hyped but controversial “exercise hormone” that researchers had hoped would be an effective obesity treatment, could make a comeback—this time in bone strengthening. -
Lured by high demand, Korean wholesaler smuggled Novo’s obesity drug Saxenda into China
November 15, 2018Anti-obesity drug Saxenda has been one of Novo Nordisk’s key growth drivers lately—and apparently, a Korean wholesaler noticed. The pharmaceutical middleman allegedly smuggled the popular drug into China, where it’s not yet approved. -
Longer-term results back Rhythm’s ultrarare obesity drug
May 16, 2018Rhythm Pharma has additional data for its first-in-class obesity therapy setmelanotide—published in the prestigious journal Nature Medicine—showing that the drug’s effects can extend for over a year.
Pharma Sources Insight January 2025
